Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950123-09-004208
Filing Date
2009-03-06
Accepted
2009-03-06 16:51:37
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q y01268e10vqza.htm 10-Q/A 240395
2 EX-31.1: CERTIFICATION y01268exv31w1.htm EX-31.1 8120
3 EX-31.2: CERTIFICATION y01268exv31w2.htm EX-31.2 8107
4 EX-32.1: CERTIFICATION y01268exv32w1.htm EX-32.1 2763
5 EX-32.2: CERTIFICATION y01268exv32w2.htm EX-32.2 2766
  Complete submission text file 0000950123-09-004208.txt   263812
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33357 | Film No.: 09663542
SIC: 2836 Biological Products, (No Diagnostic Substances)